Literature DB >> 8543591

Promotive action of acylated ascorbate on cellular DNA synthesis and growth at low doses in contrast to inhibitory action at high doses or upon combination with hyperthermia.

K Kageyama1, Y Onoyama, S Otani, M Kimura, I Matsui-Yuasa, N Nagao, N Miwa.   

Abstract

Effects of 6-O-palmitoyl ascorbate (ascorbate) developed to increase the antitumour activity of ascorbic acid on DNA synthesis and proliferation of Ehrlich ascites tumour cells were investigated. Treatment of the cells with the acylated ascorbate at 25-50 microM for 1 h resulted in no effect on DNA synthesis, assayed by pulse incorporation of [3H]thymidine after a culture period of 20 h, but led to 49%-87% enhanced DNA synthesis after 4 days, suggesting that long-term culture is required for promotion by ascorbate to occur. At a dose as high as 75 microM acylated ascorbate, however, cellular DNA synthesis was 64% inhibited after 20 h and 99% after 4 days. The results suggest that acylated ascorbate exhibits a dual action on DNA synthesis: promotion at low doses and inhibition at high doses, both of which are potentiated in a time-dependent manner. In contrast to the above-mentioned results at 37 degrees C, acylated ascorbate at 25-75 microM inhibited but did not promote DNA synthesis at 42 degrees C whatever the culture period. Similar results were exhibited when proliferation of cells cultured for a long period was investigated. At 37 degrees C, 50 microM acylated ascorbate increased the number of the cells to 3.6 times the control values after 8 days and to 1.9 times after 11 days; in contrast, a 75-microM dose decreased the cell number considerably. Combination with hyperthermia (42 degrees C) suppressed the increase and cell growth was completely inhibited at 75 microM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8543591     DOI: 10.1007/bf01203071

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Studies on the quantitative biology of hyperthermic killing of HeLa cells.

Authors:  R J Palzer; C Heidelberger
Journal:  Cancer Res       Date:  1973-02       Impact factor: 12.701

2.  The biochemical mechanism of selective heat sensitivity of cancer cells. II. Studies on nucleic acids and protein synthesis.

Authors:  B Mondovì; A Finazzi Agrò; G Rotilio; R Strom; G Moricca; A Rossi Fanelli
Journal:  Eur J Cancer       Date:  1969-05       Impact factor: 9.162

3.  Enhancement of in vitro antibody production of murine splenocytes by ascorbic acid 2-O-alpha-glucoside.

Authors:  I Yamamoto; M Tanaka; N Muto
Journal:  Int J Immunopharmacol       Date:  1993-04

4.  Effect of hyperthermia on nonhistone proteins isolated with DNA.

Authors:  S P Tomasovic; G N Turner; W C Dewey
Journal:  Radiat Res       Date:  1978-03       Impact factor: 2.841

5.  Molecular studies on the hyperthermic inhibition of DNA synthesis in Chinese hamster ovary cells.

Authors:  R S Wong; W C Dewey
Journal:  Radiat Res       Date:  1982-11       Impact factor: 2.841

6.  Control by hyperthermia of ornithine decarboxylase in Ehrlich ascites tumor cells.

Authors:  I Matsui-Yuasa; S Otani; S Morisawa; K Kageyama; Y Onoyama
Journal:  Biochim Biophys Acta       Date:  1989-12-14

7.  Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.

Authors:  M P Hacker; A R Khokhar; D B Brown; J J McCormack; I H Krakoff
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

8.  Potentiated susceptibility of ascites tumor to acyl derivatives of ascorbate caused by balanced hydrophobicity in the molecule.

Authors:  N Miwa; H Yamazaki
Journal:  Exp Cell Biol       Date:  1986

9.  Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus.

Authors:  M J Bissell; C Hatie; D A Farson; R I Schwarz; W J Soo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Depletion of extracellular cysteine with hydroxocobalamin and ascorbate in experimental murine cancer chemotherapy.

Authors:  H F Pierson; J M Fisher; M Rabinovitz
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

View more
  2 in total

1.  Anticancer effects of 6-o-palmitoyl-ascorbate combined with a capacitive-resistive electric transfer hyperthermic apparatus as compared with ascorbate in relation to ascorbyl radical generation.

Authors:  Shinya Kato; Ryoko Asada; Katsuhiro Kageyama; Yasukazu Saitoh; Nobuhiko Miwa
Journal:  Cytotechnology       Date:  2011-06-11       Impact factor: 2.058

Review 2.  Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases.

Authors:  Catalina Hoppe; Maren Freuding; Jens Büntzel; Karsten Münstedt; Jutta Hübner
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-17       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.